Cannon Financial Strategists’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$425K Sell
354
-2
-0.6% -$2.04K 0.05% 85
2026
Q1
$328K Buy
356
+8
+2% +$8.11K 0.04% 81
2025
Q4
$374K Hold
348
0.05% 72
2025
Q3
$266K Hold
348
0.04% 82
2025
Q2
$271K Hold
348
0.04% 79
2025
Q1
$288K Hold
348
0.05% 76
2024
Q4
$269K Hold
348
0.05% 80
2024
Q3
$309K Hold
348
0.05% 72
2024
Q2
$315K Hold
348
0.06% 70
2024
Q1
$271K Hold
348
0.05% 76
2023
Q4
$203K Buy
+348
New +$203K 0.04% 86

Other funds holding LLY

Cannon Financial Strategists's LLY Position: Q2 2026 in Review

Cannon Financial Strategists reduced its Eli Lilly (LLY) stake by 0.56% in Q2 2026, selling an estimated $2.04K and leaving 354 shares worth $425K. The position accounts for 0.05% of the portfolio, ranked #85.

Cannon Financial Strategists first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,640 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Cannon Financial Strategists held 354 shares of Eli Lilly worth $425K as of Q2 2026.
  • Cannon Financial Strategists sold 2 Eli Lilly shares in Q2 2026, an estimated $2.04K.
  • Eli Lilly made up 0.05% of Cannon Financial Strategists's portfolio in Q2 2026, its #85 holding.
  • Cannon Financial Strategists first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,640 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cannon Financial Strategists's 13F filing for Q2 2026, filed 7 Aug 2026.